The myeloproliferative disorders and their treatment with interferon alfa

被引：0
|
作者：
Silver, RT
机构：
来源：
MOLECULAR BIOLOGY OF HEMATOPOIESIS 5 | 1996年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：571 / 576
页数：6
相关论文
共 50 条
  • [1] TREATMENT OF THROMBOCYTOSIS IN CHRONIC MYELOPROLIFERATIVE DISORDERS WITH INTERFERON ALFA-2B
    SEEWANN, HL
    ZIKULNIG, R
    GALLHOFER, G
    SCHMID, C
    EUROPEAN JOURNAL OF CANCER, 1991, 27 : S58 - S63
  • [2] INTERFERON-ALFA CORRECTS THROMBOCYTOSIS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS
    LUDWIG, H
    LINKESCH, W
    GISSLINGER, H
    FRITZ, E
    SINZINGER, H
    RADASZKIEWICZ, T
    CHOTT, A
    FLENER, R
    MICKSCHE, M
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 25 (03) : 266 - 273
  • [3] Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders
    Beretta, L
    Caronni, M
    Vanoli, M
    Scorza, R
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 385 - 386
  • [4] Long-term treatment with interferon alfa for myeloproliferative neoplasms
    Kiladjian, Jean-Jacques
    LANCET HAEMATOLOGY, 2017, 4 (04): : E150 - E151
  • [5] Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature
    How, Joan
    Hobbs, Gabriela
    CANCERS, 2020, 12 (07) : 1 - 13
  • [6] Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Hasselbalch, Hans Carl
    Kiladjian, Jean-Jacques
    Silver, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : E564 - E565
  • [7] The role of interferon-alpha in the treatment of myeloproliferative disorders
    Fiorani, C
    Tonelli, S
    Casolari, B
    Sacchi, S
    CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (12) : 987 - 1013
  • [8] TREATMENT OF THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH INTERFERON ALPHA-2A
    TICHELLI, A
    GRATWOHL, A
    BERGER, C
    LORI, A
    WURSCH, A
    DIETERLE, A
    THOMSSEN, C
    NISSEN, C
    HOLDENER, E
    SPECK, B
    BLUT, 1989, 58 (01): : 15 - 19
  • [9] INTRODUCTION AND OVERVIEW OF INTERFERON ALFA IN MYELOPROLIFERATIVE AND HEMANGIOMATOUS DISEASES
    APPELBAUM, FR
    SEMINARS IN HEMATOLOGY, 1990, 27 (03) : 1 - 5
  • [10] Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
    Kjaer, Lasse
    Cordua, Sabrina
    Holmstrom, Morten O.
    Thomassen, Mads
    Kruse, Torben A.
    Pallisgaard, Niels
    Larsen, Thomas S.
    de Stricker, Karin
    Skov, Vibe
    Hasselbalch, Hans C.
    PLOS ONE, 2016, 11 (10):
12345